title: [Caffeine derivatives: research perspectives in antitumor and radio-modified drugs for the combined treatment of malignant brain tumors].
authors.forename: L P
authors.initials: LP
authors.lastname: Vartanian
authors.forename: M B
authors.initials: MB
authors.lastname: Kolesova
authors.forename: G F
authors.initials: GF
authors.lastname: Gornaeva
authors.forename: Iu I
authors.initials: IuI
authors.lastname: Pustovalov
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001812:Blood-Brain Barrier; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002110:Caffeine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D004260:DNA Repair / Q000187:drug effects; D006801:Humans; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D011838:Radiation-Sensitizing Agents; C017795:xanthobine; D002110:Caffeine; C104861:proksifein